Strong Clinician Preference of Aspirin Over Clopidogrel in the Antithrombotic Management of Mono and Polyvascular PAD

Strong Clinician Preference of Aspirin Over Clopidogrel in the Antithrombotic Management of Mono and Polyvascular PAD

Bibliographic Details
Main Authors:	Kinshuk Jain, Penelope Poppy Janpen Sucharitkul, Nawaz Safdar, Benoit Jauniaux, Ryan Laloo, Keely Jones, Mark Aaron Bailey, David Julian Ashbridge Scott
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	EJVES Vascular Forum
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666688X21001192

Similar Items

Treating to Target Confers Enhanced LDL Cholesterol Reductions Compared to a Fire and Forget Approach in Fontaine I/II Peripheral Arterial Disease
by: Penelope Sucharitkul, et al.
Published: (2022-01-01)

THE EFFECTIVENESS OF CLOPIDOGREL AS AN ANTITHROMBOTIC COMPARED TO TICLOPIDINE AND ASPIRIN (META-ANALYSIS)
by: Titien Siwi Hartayu, et al.
Published: (2017-05-01)

Antithrombotic effect of clopidogrel compared with aspirin during radiofrequency catheter ablation
by: Polymeropoulos, K, et al.
Published: (2005)

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?
by: Muntaner Juan, et al.
Published: (2004-01-01)

Aspirin versus clopidogrel: the wrong question?
by: Born, G, et al.
Published: (1997)

Aspirin and clopidogrel resistance: methodological challenges and opportunities
by: Armen Yuri Gasparyan
Published: (2010-03-01)

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis.
by: Shuai Tan, et al.
Published: (2015-01-01)

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy
by: Pepinghege Fenena, et al.
Published: (2011-01-01)

Mapping the antiplatelet effects of clopidogrel and aspirin by modified thromboelastography
by: Hemlata, et al.
Published: (2013-01-01)

Is clopidogrel superior to aspirin in secondary prevention of vascular disease?
by: Algra Ale, et al.
Published: (2000-11-01)

Induction of Diabetes Abolishes the Antithrombotic Effect of Clopidogrel in Apolipoprotein E–Deficient Mice
by: A. Sugidachi, et al.
Published: (2017-07-01)

Effective platelet inhibition by aspirin and clopidogrel: where are we now?
by: Tousoulis, D, et al.
Published: (2009)

Molecular genomic and epigenomic characteristics related to aspirin and clopidogrel resistance
by: Jei Kim, et al.
Published: (2024-06-01)

Aggregogram changes in COVID-19 patients treated by clopidogrel and aspirin
by: D.V. Gorelov, et al.
Published: (2024-03-01)

Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV
by: Emanuela Marcantoni, PhD, et al.
Published: (2022-11-01)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
by: Rakesh K Sharma, et al.
Published: (2009-11-01)

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease
by: Narek A. Tmoyan, et al.
Published: (2021-01-01)

Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial
by: Jin-Sin Koh, et al.
Published: (2017-02-01)

The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
by: Mesana Thierry G, et al.
Published: (2005-10-01)

Perioperative antithrombotic medication: An approach for the primary care clinician
by: Daniël J. Laäs, et al.
Published: (2024-08-01)

A Rational Approach to a De-Escalation of Double Antithrombotic Therapy: The Possibilities of Clopidogrel
by: V. V. Kashtalap, et al.
Published: (2019-10-01)

Prevalence of Aspirin and Clopidogrel Resistance in Patients with Recurrent Ischaemic Cerebrovascular Disease
by: Niyata Hananta Karunawan, et al.
Published: (2021-12-01)

Comparison of effectiveness of aspirin, clopidogrel and cilostazol monotherapy treatment in ischaemic stroke
by: Endarwati Tuti, et al.
Published: (2025-01-01)

Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants
by: Vidya Perera, et al.
Published: (2024-07-01)

Platelet Reactivity and Response to Aspirin and Clopidogrel in Patients with Platelet Count Disorders
by: Wiktor Kuliczkowski, et al.
Published: (2021-01-01)

Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
by: Bratseth Vibeke, et al.
Published: (2012-08-01)

Platelet aggregometry testing during aspirin or clopidogrel treatment and measurement of clopidogrel metabolite concentrations in dogs with protein‐losing nephropathy
by: Sarah Shropshire, et al.
Published: (2020-03-01)

Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
by: Mojtaba Khazaei, et al.
Published: (2019-03-01)

Importance of polyvascular disease (PolyVD). Prognosis, screening and therapy
by: Endre Kolossváry
Published: (2024-10-01)

Aspirin-free antithrombotic management following coronary stenting. Myth or reality?
by: Davide Capodanno, et al.
Published: (2019-02-01)

Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial
by: Rafiq Sulman, et al.
Published: (2012-04-01)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
by: Jianyu Qu, et al.
Published: (2021-06-01)

Differential effects of clopidogrel and/or aspirin on the healing of tooth extraction wound bone tissue
by: Jiaping Wang, et al.
Published: (2024-07-01)

Clopidogrel Plus Aspirin in Patients With Different Types of Single Small Subcortical Infarction
by: Guangyao Wang, et al.
Published: (2021-03-01)

Advances in Phactr1 related polyvascular disease: from bench to bedside
by: Ma Xiaoxuan, et al.
Published: (2021-12-01)

Patient with Polyvascular Atherosclerosis Acutely Complicated with Different Major Vascular Events
by: O. Koval, et al.
Published: (2020-02-01)

Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease
by: Mohammad Alkhalil, et al.
Published: (2021-03-01)

Clopidogrel with Aspirin versus Aspirin Alone following Intravenous Thrombolysis in Minor Stroke: A 1-Year Follow-Up Study
by: Hai-Ming Cao, et al.
Published: (2022-12-01)

The efficacy and adverse reaction of bleeding of clopidogrel plus aspirin as compared to aspirin alone after stroke or TIA: a systematic review.
by: Yan Huang, et al.
Published: (2013-01-01)

Clopidogrel is associated with a reduced thrombogenic response in radiofrequency ablation procedures compared to aspirin
by: Polymeropoulos, K, et al.
Published: (2006)